ORX:STO
Orexo AB
SEKÂ 1.37
arrow_downward
-1.58%(-0.022) Siku 1
6 Nov, 17:29:49 GMT +1 · SEK
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ORX...
Fungua
SEKÂ 1.47
Juu
SEKÂ 1.47
Chini
SEKÂ 1.31
Mtaji wa soko
48.05M
Wastani wa kiasi cha mauzo
elfu 320.60
Kiasi cha mauzo ya hisa
elfu 525.28
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.06
Juu kwa wiki 52
SEKÂ 36.00
Chini kwa wiki 52
SEKÂ 1.30
EPS
SEKÂ 21.73
Hisa za wawekezaji
35.13M
Idadi ya wafanyakazi
55
Fungua
SEKÂ 1.47
Juu
SEKÂ 1.47
Chini
SEKÂ 1.31
Mtaji wa soko
48.05M
Wastani wa kiasi cha mauzo
elfu 320.60
Kiasi cha mauzo ya hisa
elfu 525.28
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.06
Juu kwa wiki 52
SEKÂ 36.00
Chini kwa wiki 52
SEKÂ 1.30
EPS
SEKÂ 21.73
Hisa za wawekezaji
35.13M
Idadi ya wafanyakazi
55
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Yahoo Finance
·
dakika 17 zilizopita
Dow, S&P 500, Nasdaq Futures Rebound After Sharp AI Selloff Last Week: NVDA, AMD, VIR, SNDK In Focus
Yahoo Finance
·
dakika 54 zilizopita
Galaxy Digital (NasdaqGS:GLXY) Stock Fair Value Edges Lower As Analysts Weigh AI Buildout Risks
CryptoRank
·
dakika 31 zilizopita
S&P 500 Earnings Beats Shrink to Just 2.7%, Weakest in Four Years Despite 84% of Companies Topping Forecasts
Bloomberg
·
saa 1 iliyopita
Asian Markets at Risk of Pressure on Nvidia Probe: Markets Wrap
Wasifu
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
Kuhusu Orexo AB
Afisa Mkuu Mtendaji (CEO)Nikolaj Sørensen
Wafanyakazi55
Lilianzishwa1995
Makao makuu-
SektaHealth Care
Sekta-
Tovutiorexo.com